Industry Focus

Industry Focus

By The Motley FoolBusinessNewsBusiness News
Download on the App Store

Industry Focus episodes

  • Financials: Green Dot’s Disappointing Earnings and an Interview With Prudential’s CFO

    In the latest installment of our Between Two Fools interview series, host Jason Moser sits down with Prudential (NYSE: PRU) CFO Ken Tanji to talk about financial wellness and what the company is doing to try to improve the financial wellness of Americans. Plus, Fool.com contributor Matt Frankel, CFP talks about why Green Dot (NASDAQ: GDOT) plunged after its recent earnings report, and you’ll also hear what stocks are on our radar this week. All this and more on this week’s episode of Industry Focus: Financials.

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    36 min
  • Tech: Checking in on IPOs

    We've got our hands on the first report for recently public Pinterest! We dive in and try and figure out why the stock sold off 10% after earnings, and check in on 2018 IPOs Upwork and Docusign to see how they're faring after their first year on the market.

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    20 min
  • Tech: Checking in on IPOs

    We've got our hands on the first report for recently public Pinterest! We dive in and try and figure out why the stock sold off 10% after earnings, and check in on 2018 IPOs Upwork and Docusign to see how they're faring after their first year on the market.

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    20 min
  • Energy: A.O. Smith, Hot Stock or in Hot Water?

    If you took a hot shower this morning, there’s a good chance you got your hot water thanks to a product from A.O. Smith, America’s largest manufacturer of hot water heaters. Operating in an oligopoly market with growing demand as more of the world enters the middle class, A.O. Smith is up 9X over the last 10 years and counts itself among elite company as a dividend aristocrat.  With shares down today on a recent short report from J Capital Research, Motley Fool Analyst John Rotonti joins the show to break down the investment opportunities and risks surrounding A.O. Smith today.

    Stocks Mentioned: AOS

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter

    $50 off your first job post. Linkedin.com/fool  

    32 min
  • Energy: A.O. Smith, Hot Stock or in Hot Water?

    If you took a hot shower this morning, there’s a good chance you got your hot water thanks to a product from A.O. Smith, America’s largest manufacturer of hot water heaters. Operating in an oligopoly market with growing demand as more of the world enters the middle class, A.O. Smith is up 9X over the last 10 years and counts itself among elite company as a dividend aristocrat.  With shares down today on a recent short report from J Capital Research, Motley Fool Analyst John Rotonti joins the show to break down the investment opportunities and risks surrounding A.O. Smith today.

    Stocks Mentioned: AOS

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter

    $50 off your first job post. Linkedin.com/fool  




    32 min
  • Healthcare: Who Had the Better Quarter, Gilead Sciences or Amgen?

    It's a battle of the big bio's on this episode of Industry Focus Healthcare. Is Gilead Sciences finally overcoming its hep C headwind? Is Amgen beating back biosimilars? We dig into the details as we discuss which of these biopharma behemoths delivered better first quarter results. Stocks: GILD, AMGN

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    25 min
  • Healthcare: Who Had the Better Quarter, Gilead Sciences or Amgen?

    It's a battle of the big bio's on this episode of Industry Focus Healthcare. Is Gilead Sciences finally overcoming its hep C headwind? Is Amgen beating back biosimilars? We dig into the details as we discuss which of these biopharma behemoths delivered better first quarter results. Stocks: GILD, AMGN

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    25 min
  • CG: What to Make of MLMs

    You've undoubtedly been exposed to the multi-level marketing industry -- Facebook posts from people you went to high school with, phone calls asking you to come to Tupperware parties. Millions of Americans participate in the space, whether they call it "direct selling" "network marketing" or something else entirely. On this show, we explain why we won't invest in the industry, and how the average distributor tends to make out.

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter

    $50 off your first job post. Linkedin.com/fool

    27 min
  • CG: What to Make of MLMs

    You've undoubtedly been exposed to the multi-level marketing industry -- Facebook posts from people you went to high school with, phone calls asking you to come to Tupperware parties. Millions of Americans participate in the space, whether they call it "direct selling" "network marketing" or something else entirely. On this show, we explain why we won't invest in the industry, and how the average distributor tends to make out.

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter

    $50 off your first job post. Linkedin.com/fool

    27 min
  • Financials: A Trio of Big Financial Earnings

    In this installment of Industry Focus: Financials, we sit down for a chat with Fool analyst T.J. Piggott. Then, host Jason Moser and Fool.com contributor Matt Frankel, CFP discuss the latest earnings from Berkshire Hathaway (NYSE: BRK-A) (NYSE: BRK-B), Square (NYSE: SQ), and Markel (NYSE: MKL). And, as always, the pair shares two stocks on the top of their watch list right now.

     Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    32 min

About Industry Focus

From the publisher's feed

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at…

More shows like Industry Focus

Motley Fool Hidden Gems Investing by The Motley Fool

Motley Fool Hidden Gems Investing

3,161 Listeners

Motley Fool Answers by The Motley Fool

Motley Fool Answers

807 Listeners

Rule Breaker Investing by The Motley Fool

Rule Breaker Investing

933 Listeners

MarketFoolery by The Motley Fool

MarketFoolery

1,604 Listeners